| Literature DB >> 26029119 |
Simon Lecoutre1, Christophe Breton1.
Abstract
Based on the concept of Developmental Origin of Health and Disease, both human and animal studies have demonstrated a close link between nutrient supply perturbations in the fetus or neonate (i.e., maternal undernutrition, obesity, gestational diabetes and/or rapid catch-up growth) and increased risk of adult-onset obesity. Indeed, the adipose tissue has been recognized as a key target of developmental programming in a sex-and depot-specific manner. Despite different developmental time windows, similar mechanisms of adipose tissue programming have been described in rodents and in bigger mammals (sheep, primates). Maternal nutritional manipulations reprogram offspring's adipose tissue resulting in series of alterations: enhanced adipogenesis and lipogenesis, impaired sympathetic activity with reduced noradrenergic innervations and thermogenesis as well as low-grade inflammation. These changes affect adipose tissue development, distribution and composition predisposing offspring to fat accumulation. Modifications of hormonal tissue sensitivity (i.e., leptin, insulin, glucocorticoids) and/or epigenetic mechanisms leading to persistent changes in gene expression may account for long-lasting programming across generations.Entities:
Keywords: adipocyte; epigenetic mechanisms; fetal programming; hyperplasia; hypertrophy; inflammation; obesity
Year: 2015 PMID: 26029119 PMCID: PMC4429565 DOI: 10.3389/fphys.2015.00158
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
Figure 1Schematic representation of programmed mechanisms in offspring's adipose tissue of malnourished dams. Overall, offspring from malnourished dams display increased adipogenesis/lipogenesis and inflammation as well as decreased lipolysis within adipose tissue. Red arrows indicate programmed activation (+) or inhibition (−) of major processes controlled by hormones that may predispose offspring to fat accumulation. The accumulation of triglycerides (TG) may be due to increased esterification of either free fatty acids released from lipoproteins, catalyzed by lipoprotein lipase (LPL) (dashed arrow), or free fatty acids synthesized from glucose metabolism mainly driven by lipogenic enzymes. Leptin acting via its receptor (JAK2/STAT3 signaling pathway) may activate preadipocyte proliferation and/or inhibit lipolysis. Insulin after binding to its receptor (IRS/PI3K/Akt signaling pathway) may promote the TG formation via activation of glucose entry (i.e., increased GLUT4 translocation) (dashed arrow) and lipogenic enzymes. Insulin also shows anti-lipolytic effects and may activate adipogenesis. Increased adipogenesis and decreased lipolysis may be due to impaired activity of the sympathetic system (via noradrenaline). Glucocorticoids (GC) that bind intracellular receptor may activate adipogenesis and lipogenesis whereas they inhibit lipolysis. Thus, both increased circulating GC levels and intracellular GC sensivity (i.e., modified GR, MR, 11 β-HSD1, 11 β-HSD2 relative abundance and activities) can directly impact on adipose tissue function. The pro-inflammatory state might be due to either immune cell infiltration (dashed arrow) and/or local expression of pro-inflammatory mediators. The pro-inflammatory state may also originate, at least in part, from increased GC sensitivity within WAT.